Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Revealing Early Stages of Alzheimer's Disease with MRI

By LabMedica International staff writers
Posted on 18 May 2010
A major Australian study has provided new clues into the loss of structure in areas of the brain and its potential association with Alzheimer's disease (AD). More...
These findings suggest an accumulation of deposits of the protein amyloid-beta in a region of the brain known as the temporal inferior cortex. The region is connected to the hippocampus, which is involved in memory.

AD is characterized by two factors: a build-up of amyloid-beta plaques in the brain, and a loss of neurons. The Commonwealth Scientific and Industrial Research Organization's (CSIRO; Victoria, Australia) Preventative Health flagship theme ;leader, Dr. Cassandra Szoeke, reported the mystery for researchers was that the parts of the brain that had shrunk (atrophied) due to neuron loss were not the same as those showing increased deposits of amyloid-beta.

Using magnetic resonance imaging (MRI) scans to assess Alzheimer's disease-affected brain tissue, the researchers discovered that shrinking (atrophy) of the hippocampus was associated with plaque deposits in the temporal inferior cortex. The study's findings indicate that the increased accumulation of amyloid in the temporal inferior cortex disrupts connections with the hippocampus, causing the neurons to die. "By helping to better understand the mechanisms involved in the progression of the disease, the study may guide the development of new strategies for early diagnosis,” Dr Szoeke said.

The study involved advanced techniques for analyzing and comparing different types of brain scans. Lead researcher was Dr. Perrick Bourgeat, from the Australian e-Health Research Center (Queensland, Australia)--a joint venture between CSIRO and the Queensland Government.

The Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) Study is being undertaken by CSIRO, the University of Melbourne, Edith Cowan University (Perth), Neurosciences Australia (Victoria), and the Mental Health Institute of Victoria.

The study's findings were reported in April 2010 issue of the journal Neurology.

Related Links:
Commonwealth Scientific and Industrial Research Organization
Australian e-Health Research Center


Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Chromogenic Culture System
InTray™ COLOREX™ ECC
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.